Clinical Trials for Prinicipal Investigator: Jason Samarasena

2 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
UCI-14-30 Low Residue Diet versus Clear Liquid Diet with Split dose PEG-ELS for Colon Cleansing Prior to Colonoscopy, a randomized trial Open
UCI-16-31 [EXEMPT - RETROSPECTIVE] Importin α is a Novel Biomarker of Barrett's Esophagus (BE)-Related Dysplasia & Cancer and Promotes Growth of BE-Derived Cancer Cells by Inducing Aberrant VEGF Expression Open